These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32283900)

  • 1. Ankaferd hemostat: from molecules to medicine.
    Çiftçiler R; Haznedaroglu İC
    Turk J Med Sci; 2020 Nov; 50(SI-2):1739-1750. PubMed ID: 32283900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
    Ciftciler R; Ciftciler AE; Malkan UY; Haznedaroglu IC
    SAGE Open Med; 2020; 8():2050312120907811. PubMed ID: 32110403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study.
    Çiftçiler R; Aksu S; Dikmenoğlu Falkmarken N; Haznedaroğlu İC
    Turk J Med Sci; 2019 Feb; 49(1):356-360. PubMed ID: 30761848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses.
    Ozel-Demiralp D; Igci N; Ayhan B; Egin Y; Haznedaroglu IC; Akar N
    Clin Appl Thromb Hemost; 2012 Nov; 18(6):604-10. PubMed ID: 22327821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
    Beyazit F; Beyazit Y; Tanoglu A; Haznedaroglu IC
    Med Hypotheses; 2020 Oct; 143():110150. PubMed ID: 32763660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
    Haznedaroglu BZ; Beyazit Y; Walker SL; Haznedaroglu IC
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):21-34. PubMed ID: 22079213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.
    Goker H; Haznedaroglu IC; Ercetin S; Kirazli S; Akman U; Ozturk Y; Firat HC
    J Int Med Res; 2008; 36(1):163-70. PubMed ID: 18304416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper.
    Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach.
    Koçak E; Çelebier M; Haznedaroglu IC; Altınöz S
    Biomed Res Int; 2019; 2019():5268031. PubMed ID: 31240215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin.
    Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional proteomic analysis of Ankaferd® Blood Stopper.
    Özel Demiralp D; Haznedaroglu İC; Akar N
    Turk J Haematol; 2010 Jun; 27(2):70-7. PubMed ID: 27263447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankaferd hemostat in the management of gastrointestinal hemorrhages.
    Beyazit Y; Kekilli M; Haznedaroglu IC; Kayacetin E; Basaranoglu M
    World J Gastroenterol; 2011 Sep; 17(35):3962-70. PubMed ID: 22046083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ankaferd on anastomotic healing of colon.
    Cancan G; Teksoz S; Aytac E; Arikan AE; Erman H; Uzun H; Ozden F; Aydin O; Ozcan M
    J Invest Surg; 2014 Feb; 27(1):1-6. PubMed ID: 23987308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
    Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic Effects of Ankaferd Hemostat.
    Malkan UY; Haznedaroglu IC
    Biomed Res Int; 2022; 2022():2665903. PubMed ID: 35958818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
    Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
    Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control.
    Sogut O; Erdogan MO; Kose R; Boleken ME; Kaya H; Gokdemir MT; Ozgonul A; Iynen I; Albayrak L; Dokuzoglu MA
    Clin Appl Thromb Hemost; 2015 May; 21(4):348-53. PubMed ID: 24057394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper® using different assays.
    Mihmanli A; Ulker Z; Alpsoy L; Ezirganli S
    Hum Exp Toxicol; 2012 Aug; 31(8):780-7. PubMed ID: 22297699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ankaferd Blood Stopper on Skin Superoxide Dismutase and Catalase Activities in Warfarin-Treated Rats.
    Aktop S; Emekli-Alturfan E; Gönül O; Göçmen G; Garip H; Yarat A; Göker K
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):168-174. PubMed ID: 26354714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat.
    Uzun O; Erkan L; Haznedaroglu IC
    Arch Bronconeumol; 2014 Sep; 50(9):407-9. PubMed ID: 24491888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.